Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures (CARDIF)

This study has been terminated.
(results of interim analysis (not safety relevant))
Sponsor:
Collaborator:
Charité Neurocure AG Flöel
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01370044
First received: May 20, 2011
Last updated: July 27, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)